Related Experiment Videos
Oncogenic transformation in vitro by the hypoxic cell sensitizer misonidazole
Abstract:
The hypoxic cell sensitizer Misonidazole (Ro-07-0582) induces oncogenic transformations in the C3H/10T1/2 mouse embryo cell line cultured in vitro. A drug concentration of 0.4 mM applied to aerated cells for 3 or 6 days results in a transformation rate comparable to that observed following an X-ray dose of 1 Gray. A higher drug concentration of 6.0 mM is equivalent to 4 Gy. The combination of Misonidazole and X-rays produces a significant increase in the frequency of transformation over either drug or radiation alone, but the data are equivocal on the question of additivity vs synergism.
Insights
The hypoxic cell sensitizer Misonidazole induces cancer cell transformations, similar to X-ray radiation. Combining Misonidazole with X-rays significantly increases transformation frequency, suggesting potential therapeutic applications.
Area of Science:
- Oncology
- Radiation Biology
- Cell Biology
Background:
- Hypoxic cell sensitizers are crucial in cancer therapy.
- Misonidazole is a well-known hypoxic cell sensitizer.
- Understanding its oncogenic potential is vital for safe application.
Purpose of the Study:
- To investigate the oncogenic transformation potential of Misonidazole.
- To compare Misonidazole's transformation effects with X-ray radiation.
- To evaluate the combined effects of Misonidazole and X-rays on transformation.
Main Methods:
- Utilizing the C3H/10T1/2 mouse embryo cell line in vitro.
- Exposing aerated cells to varying concentrations of Misonidazole (0.4 mM and 6.0 mM) for 3-6 days.
- Administering X-ray radiation doses (1 Gy and 4 Gy) for comparison.
- Assessing the frequency of oncogenic transformations.
Main Results:
- Misonidazole at 0.4 mM induced transformations comparable to 1 Gy X-rays.
- Misonidazole at 6.0 mM was equivalent to 4 Gy X-rays in transformation induction.
- Combined Misonidazole and X-ray treatment significantly increased transformation rates.
Conclusions:
- Misonidazole exhibits significant oncogenic transformation potential in vitro.
- Its effects are comparable to ionizing radiation at specific doses.
- The combination therapy warrants further investigation for potential synergism.